Hello and Welcome to Patientsville.com, Your Source for all MUCOSOLVAN information. We are dedicated to provide You with MUCOSOLVAN safety information. Learn about MUCOSOLVAN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
MUCOSOLVAN Safety Reports
Total MUCOSOLVAN reports: 2.MUCOSOLVAN FDA safety alerts: No.
Reported hospitalizations: 1.
Take MUCOSOLVAN Side Effects Survey or Share Your MUCOSOLVAN Story. Read More Here.
Consumer or non-health professional from JAPAN reported MUCOSOLVAN problem on Jan 29, 2007. Female patient, 47 years of age, was diagnosed with bronchiectasis, asthma, epilepsy and was treated with MUCOSOLVAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacteria sputum identified, blood alkaline phosphatase increased, blood immunoglobulin a decreased, blood immunoglobulin g decreased, blood immunoglobulin m decreased, blood lactate dehydrogenase increased, bronchiectasis. MUCOSOLVAN dosage: 45 MG/DAY. During the same period patient was treated with ACCOLATE, TEGRETOL. Patient was hospitalized. Patient recovered.
MUCOSOLVAN problem was reported by a Health Professional from JAPAN on Feb 05, 2007. Male patient, 76 years of age, was diagnosed with insomnia and was treated with MUCOSOLVAN. After drug was administered, patient experienced the following problems/side effects: delirium, hallucination. MUCOSOLVAN dosage: 45 MG. During the same period patient was treated with TAKEPRON, MYSLEE. Patient recovered.